E. Middleton, J. Kandaswami, C. Theoharides, and T. , The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer, Pharmacol. Rev, vol.52, issue.4, pp.673-751, 2000.

M. Lopez-lazaro, Flavonoids as Anticancer Agents: Structure-Activity Relationship Study, Current Medicinal Chemistry-Anti-Cancer Agents, vol.2, issue.6, pp.691-714, 2002.
DOI : 10.2174/1568011023353714

F. Valeriote, Activity of flavone acetic acid (NSC-347512) against solid tumors of mice, Investigational ew Drugs, vol.4, issue.3, pp.207-220, 1986.

J. Plowman, V. Narayanan, D. Dykes, E. Szarvasi, P. Briet et al., Flavone acetic acid: a novel agent with preclinical antitumor activity against colon adenocarcinoma 38 in mice, Cancer Treat. Rep, issue.5, pp.70-631, 1986.

M. Bibby, J. Double, and P. Loadman, Unique chemosensitivity of MAC 16 tumours to flavone acetic acid (LM975, NSC 347512), British Journal of Cancer, vol.58, issue.3, pp.58-341, 1988.
DOI : 10.1038/bjc.1988.215

G. Pratesi, C. Manzotti, G. Damia, and M. Incalci, Response of chemically induced primary colon tumours of the mouse to flavone acetic acid (NSC 347 512), British Journal of Cancer, vol.58, issue.2, pp.58-144, 1988.
DOI : 10.1038/bjc.1988.181

R. Giavazzi, A. Garofalo, G. Damia, S. Garattini, and M. Incalci, Response to flavone acetic acid (NSC 347512) of primary and metastatic human colorectal carcinoma xenografts, British Journal of Cancer, vol.57, issue.3, pp.57-277, 1988.
DOI : 10.1038/bjc.1988.59

G. Pratesi, C. Manzotti, M. Tortoreto, R. Audisio, and F. Zunino, Differential efficacy of flavone acetic acid against liver versus lung metastases in a human tumour xenograft, British Journal of Cancer, vol.63, issue.1, pp.63-71, 1991.
DOI : 10.1038/bjc.1991.15

M. De-forni, G. Chabot, J. Armand, A. Gouyette, M. Klink-alak et al., Phase I and pharmacology study of flavone acetic acid administered two or three times weekly without alkalinization, Cancer Chemother. Pharmacol, issue.3, pp.35-219, 1995.

D. Kerr, T. Maughan, E. Newlands, G. Rustin, N. Bleehen et al., Phase II trials of flavone acetic acid in advanced malignant melanoma and colorectal carcinoma, British Journal of Cancer, vol.60, issue.1, pp.60-104, 1989.
DOI : 10.1038/bjc.1989.230

G. Chabot, M. Bissery, and A. Gouyette, Flavone acetic acid (LM-975; NSC-347512) activation to cytotoxic species in vivo and in vitro, Cancer Chemotherapy and Pharmacology, vol.9, issue.5, pp.24-273, 1989.
DOI : 10.1007/BF00304757

D. Incalci and M. , Antiproliferative properties of flavone acetic acid (NSC 347512) (LM 975), a new anticancer agent, Eur. J Cancer Clin. Oncol, issue.10, pp.23-1529, 1987.

B. Drewinko and Y. Ly, The activity of flavone acetic acid (NSC 347512) on human colon cancer cells in vitro, Investigational New Drugs, vol.4, issue.4, pp.289-293, 1986.
DOI : 10.1007/BF00173501

W. Schroyens, P. Dodion, C. Sanders, M. Loos, N. Dethier et al., In vitro chemosensitivity testing of flavone acetic acid (LM975; NSC 347512) and its diethylaminoethyl ester derivative (LM985; NSC 293015), European Journal of Cancer and Clinical Oncology, vol.23, issue.8, pp.23-1135, 1987.
DOI : 10.1016/0277-5379(87)90146-5

R. Hornung, T. Back, D. Zaharko, W. Urba, D. Longo et al., Augmentation of natural killer activity, induction of IFN and development tumor immunity during the successful treatment of established murine renal cancer using flavone acetic acid and IL-2, J Immunol, issue.10, pp.141-3671, 1988.

C. Lindsay, D. Gomez, and U. Thorgeirsson, Effect of flavone acetic acid on endothelial cell proliferation: evidence for antiangiogenic properties, Anticancer Res, vol.16, issue.1, pp.425-431, 1996.

J. Evelhoch, M. Bissery, G. Chabot, N. Simpson, C. Mccoy et al., Flavone acetic acid (NSC 347512)-induced modulation of murine tumor physiology monitored by in vivo nuclear magnetic resonance spectroscopy, Cancer Res, issue.17, pp.48-4749, 1988.

M. Bibby, J. Double, P. Loadman, and C. Duke, Reduction of Tumor Blood Flow by Flavone Acetic Acid: A Possible Component of Therapy, JNCI Journal of the National Cancer Institute, vol.81, issue.3, pp.81-216, 1989.
DOI : 10.1093/jnci/81.3.216

S. Hill, K. Williams, and J. Denekamp, Vascular collapse after flavone acetic acid: A possible mechanism of its anti-tumour action, European Journal of Cancer and Clinical Oncology, vol.25, issue.10, pp.25-1419, 1989.
DOI : 10.1016/0277-5379(89)90099-0

L. Zwi, B. Baguley, J. Gavin, and W. Wilson, Blood Flow Failure as a Major Determinant in the Antitumor Action of Flavone Acetic Acid, JNCI Journal of the National Cancer Institute, vol.81, issue.13, pp.81-1005, 1989.
DOI : 10.1093/jnci/81.13.1005

M. Bissery, F. Valeriote, G. Chabot, J. Crissman, C. Yost et al., Flavone acetic acid (NSC 347512)-induced DNA damage in Glasgow osteogenic sarcoma in vivo, Cancer Res, issue.5, pp.48-1279, 1988.

G. Chabot, Identification of new flavone-8-acetic acid metabolites using mouse microsomes and comparison with human microsomes, Drug Metab Dispos, issue.11, pp.35-2023, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00323880

D. Nelson, D. Zeldin, S. Hoffman, L. Maltais, H. Wain et al., Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants, Pharmacogenetics, vol.14, issue.1, pp.14-15, 2004.
DOI : 10.1097/00008571-200401000-00001

B. Walther, Determining the best animal model for human cytochrome P450 activities: a comparison of mouse, rat, rabbit, dog, micropig, monkey and man, Xenobiotica, issue.12, pp.30-1131, 2000.

M. Martignoni, G. Groothuis, and K. De, Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction, Expert Opinion on Drug Metabolism & Toxicology, vol.283, issue.6, pp.875-894, 2006.
DOI : 10.1097/00007890-199810270-00026

P. Hodek, P. Trefil, and M. Stiborova, Flavonoids-potent and versatile biologically active compounds interacting with cytochromes P450, Chemico-Biological Interactions, vol.139, issue.1, pp.1-21, 2002.
DOI : 10.1016/S0009-2797(01)00285-X

D. Dauzonne and P. Demerseman, -1-benzopyrans, Synthesis, vol.1990, issue.01, pp.66-70, 1990.
DOI : 10.1055/s-1990-26791

URL : https://hal.archives-ouvertes.fr/hal-00747378

D. Dauzonne, B. Folleas, L. Martinez, and G. Chabot, Synthesis and in vitro cytotoxicity of a series of 3-aminoflavones, European Journal of Medicinal Chemistry, vol.32, issue.1, pp.3271-82, 1997.
DOI : 10.1016/S0223-5234(97)84363-2

B. Bauvois, M. Puiffe, J. Bongui, S. Paillat, C. Monneret et al., Synthesis and Biological Evaluation of Novel Flavone-8-acetic Acid Derivatives as Reversible Inhibitors of Aminopeptidase N/CD13, Journal of Medicinal Chemistry, vol.46, issue.18, pp.46-3900, 2003.
DOI : 10.1021/jm021109f

C. Morisseau, J. Newman, D. Dowdy, M. Goodrow, and B. Hammock, Inhibition of Microsomal Epoxide Hydrolases by Ureas, Amides, and Amines, Chemical Research in Toxicology, vol.14, issue.4, pp.409-415, 2001.
DOI : 10.1021/tx0001732

V. Breinholt, E. Offord, C. Brouwer, S. Nielsen, K. Brosen et al., In vitro investigation of cytochrome P450-mediated metabolism of dietary flavonoids, Food and Chemical Toxicology, vol.40, issue.5, pp.40-609, 2002.
DOI : 10.1016/S0278-6915(01)00125-9

F. Guengerich, Microsomal enzymes involved in toxicology -Analysis and separation. In: Principles and methods of toxicology(Ed. Hayes AW), pp.609-634, 1982.

J. Harris, A. Rahman, B. Kim, F. Guengerich, and J. Collins, Metabolism of taxol by human hepatic microsomes and liver slices: participation of cytochrome P450 3A4 and an unknown P450 enzyme, Cancer Res, issue.15, pp.54-4026, 1994.

F. Guengerich, D. Kim, and M. Iwasaki, Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects, Chemical Research in Toxicology, vol.4, issue.2, pp.168-179, 1991.
DOI : 10.1021/tx00020a008

M. Maurice, L. Pichard, M. Daujat, I. Fabre, H. Joyeux et al., Effects of imidazole derivatives on cytochromes P450 from human hepatocytes in primary culture, FASEB J, vol.6, issue.2, pp.752-758, 1992.

DOI : 10.1124/dmd.105.006866

J. Pan, Q. Xiang, and S. Ball, Use of a novel real-time quantitative reverse transcriptionpolymerase chain reaction method to study the effects of cytokines on cytochrome P450 mRNA expression in mouse liver, Drug Metab Dispos, issue.6, pp.28-709, 2000.

M. Martignoni, R. Kanter, P. Grossi, G. Saturno, E. Barbaria et al., An in vivo and in vitro comparison of CYP gene induction in mice using liver slices and quantitative RT-PCR, Toxicology in Vitro, vol.20, issue.1, pp.125-131, 2006.
DOI : 10.1016/j.tiv.2005.06.040

R. Rutledge, Sigmoidal curve-fitting redefines quantitative real-time PCR with the prospective of developing automated high-throughput applications. ucleic Acids Res, pp.32-178, 2004.

H. Rhinn, D. Scherman, and V. Escriou, One-step quantification of single-stranded DNA in the presence of RNA using Oligreen in a real-time polymerase chain reaction thermocycler, Analytical Biochemistry, vol.372, issue.1, pp.372-116, 2008.
DOI : 10.1016/j.ab.2007.08.023

F. Guengerich, Cytochrome P450 oxidations in the generation of reactive electrophiles: epoxidation and related reactions, Archives of Biochemistry and Biophysics, vol.409, issue.1, pp.59-71, 2003.
DOI : 10.1016/S0003-9861(02)00415-0

K. Vyas, T. Shibata, R. Highet, H. Yeh, P. Thomas et al., Metabolism of alpha-naphthoflavone and beta-naphthoflavone by rat liver microsomes and highly purified reconstituted cytochrome P-450 systems, J. Biol. Chem, issue.9, pp.258-5649, 1983.

J. Reiners, J. Clift, R. Mathieu, and P. , Suppression of cell cycle progression by flavonoids: dependence on the aryl hydrocarbon receptor, Carcinogenesis, vol.20, issue.8, pp.20-1561, 1999.
DOI : 10.1093/carcin/20.8.1561

T. Gasiewicz, A. Kende, G. Rucci, B. Whitney, and J. Willey, Analysis of structural requirements for ah receptor antagonist activity: Ellipticines, flavones, and related compounds, Biochemical Pharmacology, vol.52, issue.11, pp.52-1787, 1996.
DOI : 10.1016/S0006-2952(96)00600-4

Y. Lu, M. Santostefano, B. Cunningham, M. Threadgill, and S. Safe, Substituted flavones as aryl hydrocarbon (Ah) receptor agonists and antagonists, Biochemical Pharmacology, vol.51, issue.8, pp.51-1077, 1996.
DOI : 10.1016/0006-2952(96)00063-9

M. Suschetet, Differential effects of nonhydroxylated flavonoids as inducers of cytochrome P450 1A and 2B isozymes in rat liver, Toxicol Appl Pharmacol, vol.136, issue.2, pp.348-353, 1996.

Y. Pommier, Activation of aminoflavone (NSC 686288) by a sulfotransferase is required for the antiproliferative effect of the drug and for induction of histone ?-H2AX, Cancer Res, issue.19, pp.66-9656, 2006.